Protea Biosciences Expands Bioanalytical Services

Protea Biosciences Group, Inc. is expanding its bioanalytical services business into a new, 11,000 sq.-ft. facility in Morgantown, WV. The new space will enhance current mass spectrometry services by providing additional instrumentation and increased analytical capabilities, including the use of the LAESI DP-1000 system for distribution profiling of biomolecules. The new facility is expected to be operational by the end of April.

“This expansion allows us to better support our customers by increasing our overall service capabilities, and it enables the enhancement of our portfolio of solutions.” said Alessandro Baldi, vice president and general manager at Protea. “The addition of LAESI-based services gives us the opportunity to perform direct ionization and 2D-3D mapping of biological samples, without the need for time consuming sample preparation, which will increase our overall throughput and empower researchers with data that was previously unimaginable.”

The Bioanalytical Services Division specializes in biomarker discovery services, absolute quantitation of large molecules, MRM-based assays, and global proteome characterization. The LAESI-based services will include analysis of tissues, living cells and colonies, TLC plate mapping, as well as high throughput biofluid analysis and molecular quantitation studies.